Manuscripts
Showing 1572 manuscripts.
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Citation
Rowena Espina, Mauricio Pinilla, Edmund V Capparelli, Alice M Stek, Mark Mirochnick, Emily Barr, Brookie M Best, Adriana Weinberg, IMPAACT P1026s Protocol Team, Jaime G Deville, Irma L Febo, Mikhaela Cielo, Kathleen George, Kayla Denson, Kittipong Rungruengthanakit, David E Shapiro, Elizabeth Smith, Nahida Chakhtoura, James F Rooney, Kristina M Brooks, Richard Haubrich, Jeremiah D Momper. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. AIDS. 2021. 35: 407-417. PMID: 33252495Year
          2021      
Journal
          AIDS      
Study
          P1026S      
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Citation
Camlin Tierney, Bryan Nelson, Anne Coletti, Yvonne Bryson, Mark Cotton, Stephen Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh Naidoo, Rohan Hazra, Theodore Ruel, Patrick Jean-Philippe, Edmund Capparelli, Ellen Chadwick. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021. 8: e149-e157. PMID: 33242457Year
          2021      
Journal
          Lancet HIV      
Study
          P1115      
Pharmacokinetics and safety of maraviroc in neonates
Citation
Ellen Chadwick, Pearl Samson, Kevin Butler, IMPAACT 2007 Study Team, John Moye, Elizabeth Smith, Sarah Bradford, Christina Reding, Sisinyana Mathiba, Sherika Hanley, Mariam Aziz, James Homans, Edward Acosta, William Murtaugh, Manoli Vourvahis, Lynn Mcfadyen, Julia Rosebush, Katy Hayward, Brookie Best, Mark Mirochnick. Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021. 35: 419-427. PMID: 33252481Year
          2021      
Journal
          AIDS      
Study
          IMPAACT 2007      
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
Citation
Dorothy Sebikari , Mary Glenn Fowler, Jim Aizire, George K Siberry , Sufia Dadabhai, PROMISE P1084s study team, Admire Zanga, Cynthia Mukwasi-Kahari, Tichaona Vhembo, Avy Violari, Gerard Theron, Dhayandre Moodley , Kathleen George, Bo Fan, Markus J Sommer, Renee Browning, Lynne M Mofenson, Lynda Stranix-Chibanda, John Shepherd, Camlin Tierney, Bryan Nelson. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial. PLoS One. 2021. 16: e0246272. PMID: 33544759Year
          2021      
Journal
          PLoS One      
Study
          P1084s      
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Citation
Benjamin Johnston, Jeremiah D. Momper, Chelsea Krotje, Roger L. Shapiro, Lee Fairlie, Navdeep Thoofer, Risa Hoffman, James F. Rooney, Paul E. Sax, Lisa Frenkel, Sikhulile Moyo, K. Rivet Amico, Nahida Chakhtoura, Lameck Chinula, Jeffrey S. A. Stringer, Judith Currier, Gaerolwe Masheto, IMPAACT 2010/VESTED study team and investigators, Shahin Lockman, Violet Korutaro, Sean Brummel, Haseena Cassim, Lauren Ziemba, Blandina Mmbaga, Lynda Stranix-Chibanda, Esau Joao, Katie McCarthy, Sherika Hanley, Anne Coletti, Lynette Purdue, Patrick Jean-Philippe, Lewis Ball Holmes. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021. 397: 1276-92. PMID: 33812487Year
          2021      
Journal
          Lancet      
Study
          IMPAACT 2010      
IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation
Citation
Geri R Doneberg, Dorothy E. Dow, Suad Kapetanovic, Janice Buckley, Tebogo Jacqueline Kakhu, Portia Kamthunzi, Limbika A. Maliwichi, Tichaona Vhembo, Tariro Dianah Chawana, Teacler Nematadzira, Jennifer Libous, Nicole A. Montañez. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Frontiers in Reproductive Health. 2021. 3: 1-9. PMID: 36303985Year
          2021      
Journal
          Frontiers in Reproductive Health      
Study
          IMPAACT 2016      
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial
Citation
PROMISE Study Team, Mauricio Pinilla, Mary Glenn Fowler, Kathleen George, George K. Siberry, Jim Aizire, Godwin Chipoka, Macpherson Mallewa, Megeshinee Naidoo, Teacler Nematadzira, Bangani Kusakara, Avy Violari, Tapiwa Mbengeranwa, Boniface Njau, Lee Fairlie, Gerard Theron, Mwangelwa Mubiana-Mbewe, Lynda Stranix-Chibanda, Sandhya Khadse, Camlin Tierney, Renee Browning. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One. 2021. 16: e0255250. PMID: 34415933Year
          2021      
Journal
          PLoS One      
Study
          P1084s      
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States
Citation
Betsy D Kennard, IMPAACT 2002 team, Graham J Emslie, Kathryn Lypen, Sarah Buisson, Adriana Weinberg, Laura B Whiteley, Shirley Traite, Chelsea Krotje, Lauren Harriff, Ellen Townley, Amber Bunch, Murli Purswani, Ray Shaw, Stephen A Spector, Larry K Brown, Allison Agwu, Miriam Chernoff, David E Shapiro. Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2021. 88(5): 497-505. PMID: 34483297Year
          2021      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Study
          IMPAACT 2002      
Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa
Citation
Violet Korutaro, Clemensia Nakabiito, Maysebole Masenya , Kathryn Lypen , Emily Brown, Mustafa E Ibrahim, Jenna Yager, Lubbe Wiesner, Benjamin Johnston, Lynda Stranix-Chibanda, K Rivet Amico , Peter L Anderson, James F Rooney , Deborah Kacanek, Nahida Chakhtoura, Sybil Hosek, Hans M L Spiegel, Sharon Huang, Benjamin H Chi, Teacler G Nematadzira, IMPAACT 2009 team, Frank Taulo. Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa. Clinical Infectious Diseases. 2021. PMID: 33341883Year
          2021      
Journal
          Clinical Infectious Diseases      
Study
          IMPAACT 2009       
Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial
Citation
Lynne Mofenson, James V. Lavery, Grace John-Stewart, Patricia Flynn, Gerhard Theron, Shrikhant I. Bangdiwala, Dhayendre Moodley, Lameck Chinula, Lee Fairlie, Tumalano Sekoto, Tebogo J. Kakhu, Avy Violari, Sufia Dadabhai, Katie McCarthy, Seema K. Shah, Mary Glenn Fowler, Alex John London. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clinical Trials. 2021. 18: 681-689. PMID: 34524048Year
          2021      
Journal
          Clinical Trials      
Study
          1077HS,          1077FF,          1077BF